Market Tracker

10/23 8:50am ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.36
Data as of Oct 22
 -0.10 / -6.85%
Today’s Change
1.11
Today|||52-Week Range
2.26
-34.30%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.46
Today’s open1.46
Day’s range-- - --
Volume411,728
Average volume (3 months)604,286
Market cap$204.9M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+22.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDRAIdera Pharmaceutical...+0.07+2.94%
ALIMAlimera Sciences Inc+0.04+0.84%
HRTXHeron Therapeutics I...-0.06-0.83%
ATNMActinium Pharmaceuti...-0.17-2.35%
Data as of 10/22/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Rick Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts